One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1182/blood-2018-156
Copy DOI
Export
Save
Share
Cite Journal: Blood |  Publication Date: Nov 29, 2018 |
 Citations: 18 |
Affiliation: National and Kapodistrian University of Athens, NIHR Surgical Reconstruction and Microbiology Research Centre, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer, University of Barcelona, Hospital Clínic de Barcelona, Instituto Tropical de Medicina Reprodutiva, University of Chicago Medical Center, Janssen (United States), Japanese Red Cross Medical Center, Semmelweis University, Université Catholique de Louvain, University of Würzburg, Regional Clinical Hospital named after II Mechnikov, Medical University of Silesia, Leicester Royal Infirmary, University of Perugia, Fondazione Gimema Onlus, Matsuyama Red Cross Hospital, Saratov Research Institute of Traumatology and Orthopedics, University Hospital Brno, Janssen (Belgium), Clinica Universidad de Navarra, Champalimaud Foundation, University of Bologna, Seoul National University, Instituto de Investigación Biomédica de Salamanca
One-Year Update of a Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Patients (Pts) with Transplant-Ineligible Newly Diagnosed Multiple Myeloma (NDMM): Alcyone
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
